Back to filter

Related topics

Factors Affecting Petri Dish Condensation in Tissue Culture (CU) Chambers

Percival Scientific

Nov 29, 2023

In this report, we will investigate the effects of infrared lighting, light intensity, stacking, as well as constant...

Visualization of spatial distribution of hemoglobin with various oxygen saturations in small animals


Nov 28, 2023

With the aid of our uniquely developed device and analysis software, our primary objective is to map the spatial...

A fluorescent reporter system for anaerobic thermophiles

COY laboratory products

Nov 27, 2023

Anaerobic microorganisms are key effectors for the sustainable production of biofuels and biochemicals, as they...

Vizgen webinar: spatial relationships in Developmental Biology


Nov 21, 2023

MERFISH integrates spatial transcriptomics technology with high resolution spatial imaging, In this webinar we will...

ACCELA educational webinar: Drive key insights and discoveries with new live cell analysis applications for eSight

Agilent technologies

Nov 14, 2023

The xCELLigence RTCA eSight enables simultaneous real time biosensor impedance-based and...

NanoCellect webinar: Plant Potential - Gentle Cell Sorting for Enhanced Plant Biology Workflows


Nov 3, 2023

Gentle cell sorting is a useful tool to increase the efficiency of plant biology workflows that include gene...

SIMOA-based analysis of plasma NFL levels in MCI and AD patients


Nov 3, 2023

The single-molecule array assay (SIMOA)-based detection of neurofilament light (NFL) chain could be useful in...

Single Cell Deposition: the cornerstone of Flow Cytometry for cellular analysis and manipulation


Nov 2, 2023

One notable technology for harnessing the power of single cell deposition is the NanoCellect WOLF G2 Cell Sorter and N1...

Single cell genotypic and phenotypic analysis of residual disease in acute myeloid leukemia

Mission Bio

Nov 1, 2023

Measurable residual disease (MRD), defined as the population of cancer cells which persists following therapy, serves...

Emulate in vivo conditions – introduce shear flow to your experiments with BioFlux system

Fluxion Biosciences

Oct 31, 2023

Most research is still conducted in vitro without the presence of flow. We use the BioFlux System to give you the...

Show all topics (10)

Transcriptome-Informed Approach to Drug Discovery

Jul 12, 2022

In a previous study, we demonstrated that transcriptomic profiles generated using the proprietary HTG Transcriptome Panel (HTP) support a transcriptome-informed drug discovery paradigm. Specifically, we demonstrated that closely related compounds were differentiated by their mRNA profiles, and that relevant biological information could be gleaned using the resulting expression data. This first proof of concept study used wellcharacterized compounds known to inhibit mTOR— itself a highly studied target—which allowed us to compare HTP data to those in public databases, then verify the biological findings using the literature to build confidence in the process. However, while the data compared favorably to previous studies, and indeed even uncovered novel biology, the scope of the first study was limited to transcriptome-based characterization of compounds, without a continuation to refinement of compound design based on the transcriptomic data. In this white paper, we build further toward true transcriptomeinformed drug design using the HTP, this time focusing on a small number of early-stage hits against our first therapeutic target of emphasis, here referred to as “HTGT1,” an undisclosed RNA modifying protein (RMP). RMPs regulate the modification of cellular RNAs. Over 170 RNA modifications have been described; collectively, these modified RNAs are known as the epitranscriptome.8,9 Modifications of RNA serve as an additional layer of control for regulation of location, stability, and fate. Numerous studies associate RMPs and/or the epitranscriptome with disease development and progression,demonstrating the importance of exquisite control of cellular RNAs. One advantage of an RMP target is that a modified sample preparation process allows the use of the HTP for identification and quantitation of the RNA targets of HTGT1. Between the transcriptomic profiles, modification profiles, and in vitro inhibition (IC50) data, each compound may thus be assessed for inhibition, mechanism of action, and downstream effects, prior to in vitro efficacy studies. The results can then be used to guide the refinement of the compound design. The results presented below support our previous observation that changes in the structure of a small molecule meaningfully affect the transcriptomic profile of cells treated with that compound. More importantly, the profiles support an understanding of how these compounds affect the cell, and how the cellular background modulates those effects. Through the examples below, we demonstrate how such insights may be utilized to de-risk early-stage hit compounds.

Learn more, be nice to your cells.

Scientific paper

Get more info

Katarzyna Nazarewicz

Country manager



+48 797 701 027

Send Message

Brand profile

HTG Molecular Diagnostics

A provider of instruments, reagents, and services for molecular profiling applications. The company developed its HTG Edge instrument platform and a portfolio of multiplexed profiling panels that leverage HTG’s proprietary nuclease protection chemistry.

Related products

Solution for quantitative analysis of hundreds or thousands of targeted RNAs from a single assay.

show detail

We supply and support Life-Science Technologies in the territory of Central and Eastern Europe.

Czech Republic